UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

PloS one, 2015-08, Vol.10 (8), p.e0135101

2015

Volltextzugriff (PDF)

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

Journal of translational medicine, 2022-12, Vol.20 (1), p.606-606, Article 606

2022

Volltextzugriff (PDF)

The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers

British journal of cancer, 2024-05, Vol.130 (11), p.1875-1884

2024

Volltextzugriff (PDF)

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

The American journal of pathology, 2010-10, Vol.177 (4), p.1611-1617

2010

Volltextzugriff (PDF)

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array

Cancer research (Chicago, Ill.), 2006-12, Vol.66 (23), p.11172-11178

2006

Volltextzugriff (PDF)

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

The American journal of surgical pathology, 2011-06, Vol.35 (6), p.904-912

2011

Volltextzugriff (PDF)

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

Scientific reports, 2020-11, Vol.10 (1), p.20678-20678, Article 20678

2020

Volltextzugriff (PDF)

Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA

Nucleic acids research, 2004, Vol.32 (9), p.e69-e69

2004

Volltextzugriff (PDF)

Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma

Stem cells (Dayton, Ohio), 2008-06, Vol.26 (6), p.1414-1424

2008

Volltextzugriff (PDF)

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

Modern pathology, 2009-09, Vol.22 (9), p.1243-1250

2009

Volltextzugriff (PDF)

Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth

Clinical cancer research, 2008-09, Vol.14 (17), p.5437-5446

2008

Volltextzugriff (PDF)

Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups

Cancer research (Chicago, Ill.), 2005, Vol.65 (1), p.76-84

2005

Volltextzugriff (PDF)

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

Oncotarget, 2016-08, Vol.7 (35), p.56933-56943

2016

Volltextzugriff (PDF)

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

Cancers, 2020-10, Vol.12 (10), p.3043

2020

Volltextzugriff (PDF)

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Gynecologic oncology, 2011-10, Vol.123 (1), p.13-18

2011

Volltextzugriff (PDF)

Abstract 3985: GDF15 expression level impacts the canonical pathways of the tumor microenvironment and ovarian tumors with wild-type p53 in response to chemotherapy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3985-3985

2020

Volltextzugriff (PDF)

Abstract 6279: Estrogen signaling in low-grade serous ovarian carcinoma

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6279-6279

2024

Volltextzugriff (PDF)

Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS G12D or KRAS G12V mutations

Scientific reports, 2020-11, Vol.10 (1), p.20678

2020

Volltextzugriff (PDF)

Abstract 3242: The role of SERPINE1 in trametinib resistance in low-grade ovarian serous cancer cell line

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3242-3242

2022

Volltextzugriff (PDF)

Abstract 4697: The PI3K/mTOR pathway is a potential therapeutic target in cancers with ARID1A mutations

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4697-4697

2015

Volltextzugriff (PDF)

Overexpression of Sema3E and Sema5A in pilocytic astrocytoma

Advances in modern oncology research, 2017-10, Vol.3 (5)

2017

Volltextzugriff (PDF)

Abstract 2129A: Clinical implications of infrequent BRAF mutation in advanced stage low-grade ovarian serous carcinomas

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2129-2129A

2010

Volltextzugriff (PDF)

Abstract 363A: PAX2 is an oncogene in type I ovarian cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.363-363A

2010

Volltextzugriff (PDF)

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas: e0135101

PloS one, 2015-08, Vol.10 (8)

2015

Volltextzugriff (PDF)

Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133 super(+) Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma

Stem cells (Dayton, Ohio), 2008-06, Vol.26 (6), p.1414-1424

2008

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(68)
Bücher
(1)

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(35)
Humans
(27)
Female
(19)
Oncology
(15)
Animals
(11)
Ovarian Cancer
(9)
Tumors
(9)
Ovarian Neoplasms - Genetics
(8)
Biological And Medical Sciences
(7)
Gene Expression Regulation, Neoplastic
(7)
Ovarian Neoplasms - Pathology
(7)
Adult
(6)
Cell Line, Tumor
(6)
Cystadenocarcinoma, Serous - Genetics
(6)
Cystadenocarcinoma, Serous - Pathology
(6)
Male
(6)
Medical Sciences
(6)
Middle Aged
(6)
Mutation
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA

Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth

Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Abstract 3985: GDF15 expression level impacts the canonical pathways of the tumor microenvironment and ovarian tumors with wild-type p53 in response to chemotherapy

Abstract 6279: Estrogen signaling in low-grade serous ovarian carcinoma

Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS G12D or KRAS G12V mutations

Abstract 3242: The role of SERPINE1 in trametinib resistance in low-grade ovarian serous cancer cell line

Abstract 4697: The PI3K/mTOR pathway is a potential therapeutic target in cancers with ARID1A mutations

Overexpression of Sema3E and Sema5A in pilocytic astrocytoma

Abstract 2129A: Clinical implications of infrequent BRAF mutation in advanced stage low-grade ovarian serous carcinomas

Abstract 363A: PAX2 is an oncogene in type I ovarian cancer

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas: e0135101

Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133 super(+) Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma

Suchergebnisse filtern